CSIMarket
 

Carlisle Companies Incorporated  (CSL)
Other Ticker:  
 

Carlisle Companies Incorporated's Working Capital Per Sales

CSL's Working Capital and Revenue growth



CSL Working Capital Per Revenue (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Working Capital Change 122.61 % 27.75 % 16.98 % 18.87 % -0.38 %
Y / Y Revenue Change -29.78 % -17.38 % -21.22 % 12.94 % 36.37 %
Working Capital Per Revenue 0.32 0.23 0.2 0.18 0.18
Total Ranking # 1386 # 1670 # 216 # 379 # 697
Seq. Working Capital Change 67.63 % 32.87 % 4.42 % -4.29 % -3.8 %
Seq. Revenue Change -17.44 % 29.45 % -18.96 % -18.92 % -2.86 %





Comment on CSL's Working Capital Per Revenue in the third quarter 2023
Carlisle Companies Incorporated's Working Capital Per Revenue sequentially grew to 0.32 during the Q3 2023, above the company average. Due to increase of revenue in the Q3 2023 year on year by -29.78%.

Within Healthcare sector 27 other companies have achieved lower Working Capital Per Revenue during the Q3 2023. While Carlisle Companies Incorporated Working Capital Per Revenue overall ranking has impoved so far in the Q3 2023 to 1386, from total ranking in the second quarter 2023 at 1670.
Working Capital Per Revenue Ranking
Within: No.
Industry # 4
Sector # 28
S&P 500 # 1386


Working Capital Per Revenue Statistics
High Average Low
0.53
0.29
0.18
(Dec. 30, 2014)   (Sep 30 2022)



Financial Statements
Carlisle Companies Incorporated's Working Capital $ 2,807 Millions Visit CSL's Balance sheet
Carlisle Companies Incorporated's Revenues $ 1,260 Millions Visit CSL's Income Statement
Where are CSL's Sales coming from? Visit CSL's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Sep 30 2023, within Healthcare Sector Working Capital Per Revenue
Intuitive Surgical Inc   0.88 
Staar Surgical Company  0.88 
Talkspace Inc   0.87 
Globus Medical Inc   0.87 
Alpha Pro Tech Ltd   0.87 
Durect Corp  0.86 
Titan Pharmaceuticals Inc   0.86 
10x Genomics Inc   0.86 
Incyte Corporation  0.85 
Plus Therapeutics Inc   0.85 
Corcept Therapeutics Inc  0.85 
Moderna Inc   0.85 
Inspire Medical Systems inc   0.85 
Heron Therapeutics Inc   0.85 
Shockwave Medical Inc   0.85 
Akoya Biosciences Inc   0.84 
Tg Therapeutics Inc   0.84 
Milestone Scientific Inc   0.83 
Equillium Inc   0.83 
Logicmark Inc   0.82 
Scientific Industries Inc   0.82 
Nutriband Inc   0.82 
Inari Medical Inc   0.82 
Anika Therapeutics Inc   0.82 
Cytomx Therapeutics Inc   0.82 
Halozyme Therapeutics Inc   0.81 
Taysha Gene Therapies Inc   0.81 
Vericel Corporation  0.80 
Clever Leaves Holdings Inc   0.80 
Kiniksa Pharmaceuticals ltd   0.80 
Date modified: 2023-10-28T10:22:12+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com